Publication
Optimal Neoadjuvant Approach for Resectable Esophageal Cancer in the Era of Immunotherapy.
Guo Lin, Fan Ge, Yunsong Liu, Yu Men, Zhouguang Hui
International journal of cancerOct 1, 2026PMID 42163537doi:10.1002/ijc.70521 PMC13432334Journal ArticleNetwork Meta-AnalysispubmedProvenance
- Source
- PubMed
- Retrieved
- Oct 1, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261001-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Neoadjuvant immunotherapy has emerged as a promising strategy for patients with resectable esophageal cancer (EC), yet the optimal therapeutic approach remains unclear. We performed an updated network meta-analysis to compare the efficacy and safety of current neoadjuvant immunotherapy-based…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Esophageal Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.